Semax Peptide research-grade
Semax Peptide
$50.00 $77.00Price range: $50.00 through $77.00 Select options

Semax Peptide

Price range: $50.00 through $77.00

Research-grade Semax Peptide for laboratory investigation. For Research Use Only. Not for human use.

For Research Use Only — Not for Human Consumption
Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Accepted Payment Methods

For Research Use Only. Not for human use.

Semax Peptide research-grade

Overview

Semax Peptide is supplied as a research-grade catalog material for controlled laboratory investigation.

Laboratories choose this item when protocols need clear identification, consistent labeling, and documentation suitable for reproducible experimental workflows.

Catalog packaging and research-use labeling help purchasing and bench teams keep procurement records aligned with the physical vial.

Research Context for Semax Peptide

Work involving Semax Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

  • Research-grade material intended for laboratory investigation only
  • Catalog labeling aligned with research procurement channels
  • Suitable for method development and comparative assay workflows
  • Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of Semax Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source Semax Peptide

Procurement and research teams often select this catalog item because it supports:

  • Clear research-use labeling for compliance-aligned purchasing
  • Consistent product identification across multi-lot studies
  • Fit for reference, screening, and mechanistic laboratory models
  • Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with Semax Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using Semax Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of Semax Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 133 PubMed records. Displaying 10 per page.

  1. Panikratova YR et al. (2020). Functional Connectomic Approach to Studying Selank and Semax Effects [PMID: 32342318]

    Laboratory literature summary: Functional Connectomic Approach to Studying Selank and Semax Effects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  2. Liu R et al. (2025). Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and… [PMID: 40692165]

    Laboratory literature summary: Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  3. Magrì A et al. (2016). Influence of the N-terminus acetylation of Semax, a synthetic analog of ACTH(4-10), on… [PMID: 27586814]

    Laboratory literature summary: Influence of the N-terminus acetylation of Semax, a synthetic analog of ACTH(4-10), on copper(II) and zinc(II) coordination and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  4. Radchenko AI et al. (2025). The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological… [PMID: 41479572]

    Laboratory literature summary: The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  5. Dmitrieva VG et al. (2010). Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor… [PMID: 19633950]

    Laboratory literature summary: Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  6. Medvedeva EV et al. (2014). The peptide semax affects the expression of genes related to the immune and vascular… [PMID: 24661604]

    Laboratory literature summary: The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  7. Eremin KO et al. (2005). Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and… [PMID: 16362768]

    Laboratory literature summary: Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  8. Gusev EI et al. (2018). Laboratory research record on Semax [PMID: 29798983]

    PubMed laboratory record discussing Semax in a research context. Review the full methods and limitations on PubMed; research use only.

  9. Glazova NY et al. (2021). Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical… [PMID: 33418449]

    Laboratory literature summary: Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  10. Lebedeva IS et al. (2018). Effects of Semax on the Default Mode Network of the Brain [PMID: 30225715]

    Laboratory literature summary: Effects of Semax on the Default Mode Network of the Brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  11. Dolotov OV et al. (2006). Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases… [PMID: 16635254]

    Laboratory literature summary: Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  12. Medvedeva EV et al. (2017). Semax, an analog of ACTH((4-7)), regulates expression of immune response genes during… [PMID: 28255762]

    Laboratory literature summary: Semax, an analog of ACTH((4-7)), regulates expression of immune response genes during ischemic brain injury in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  13. Inozemtsev AN et al. (2016). Semax prevents learning and memory inhibition by heavy metals [PMID: 27411820]

    Laboratory literature summary: Semax prevents learning and memory inhibition by heavy metals. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  14. Sciacca MFM et al. (2022). Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and… [PMID: 35080861]

    Laboratory literature summary: Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  15. Filippenkov IB et al. (2020). Novel Insights into the Protective Properties of ACTH((4-7))PGP (Semax) Peptide at the… [PMID: 32580520]

    Laboratory literature summary: Novel Insights into the Protective Properties of ACTH((4-7))PGP (Semax) Peptide at the Transcriptome Level Following Cerebral…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  16. Tomasello MF et al. (2025). Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and… [PMID: 40496623]

    Laboratory literature summary: Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  17. Manchenko DM et al. (2010). [Nootropic and analgesic effects of Semax following different routes of administration] [PMID: 21268834]

    Laboratory literature summary: [Nootropic and analgesic effects of Semax following different routes of administration]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  18. Pae CU (2008). Investigational possibility of "Semax" for depression [PMID: 18204410]

    Laboratory literature summary: investigational possibility of "Semax" for depression. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  19. Sudarkina OY et al. (2021). Brain Protein Expression Profile Confirms the Protective Effect of the ACTH((4-7))PGP… [PMID: 34201112]

    Laboratory literature summary: Brain Protein Expression Profile Confirms the Protective Effect of the ACTH((4-7))PGP Peptide (Semax) in a Rat Model of Cerebral…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  20. Tabbì G et al. (2015). Semax, an ACTH4-10 peptide analog with high affinity for copper(II) ion and protective… [PMID: 25310602]

    Laboratory literature summary: Semax, an ACTH4-10 peptide analog with high affinity for copper(II) ion and protective ability against metal induced cell toxicity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  21. Liapina LA et al. (2006). [Comparison of anticoagulant effects of regulatory proline-containing oligopeptides.… [PMID: 16634437]

    Laboratory literature summary: [Comparison of anticoagulant effects of regulatory proline-containing oligopeptides. Specificity of glyprolines, semax, and selank and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  22. Grivennikov IA et al. (2008). Effects of behaviorally active ACTH (4-10) analogue – Semax on rat basal forebrain… [PMID: 18431004]

    Laboratory literature summary: Effects of behaviorally active ACTH (4-10) analogue – Semax on rat basal forebrain cholinergic neurons. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  23. Tsai SJ (2007). Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the… [PMID: 16996699]

    Laboratory literature summary: Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the investigation of attention-deficit hyperactivity disorder…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  24. Volodina MA et al. (2012). Laboratory research record on Semax [PMID: 22803132]

    PubMed laboratory record discussing Semax in a research context. Review the full methods and limitations on PubMed; research use only.

  25. Malyshev AV et al. (2013). Semax corrects brain dysfunction caused by prenatal introduction of valproic acid [PMID: 23821048]

    Laboratory literature summary: Semax corrects brain dysfunction caused by prenatal introduction of valproic acid. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  26. Slominsky PA et al. (2017). Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like… [PMID: 28702721]

    Laboratory literature summary: Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like neurodegeneration research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  27. Dolotov OV et al. (2006). Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB… [PMID: 16996037]

    Laboratory literature summary: Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  28. Dergunova LV et al. (2021). [The Peptide Drug ACTH(4-7)PGP (Semax) Suppresses mRNA Transcripts Encoding… [PMID: 34097675]

    Laboratory literature summary: [The Peptide Drug ACTH(4-7)PGP (Semax) Suppresses mRNA Transcripts Encoding Proinflammatory Mediators Induced by Reversible Ischemia of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  29. Svishcheva MV et al. (2020). Composition of Colon Microbiota in Rats studied with ACTH(4-7)-PGP Peptide (Semax)… [PMID: 32737723]

    Laboratory literature summary: Composition of Colon Microbiota in Rats studied with ACTH(4-7)-PGP Peptide (Semax) under Conditions of Restraint Stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  30. Sharonova IN et al. (2018). Modulation of GABA- and Glycine-Activated Ionic Currents with Semax in Isolated… [PMID: 29577196]

    Laboratory literature summary: Modulation of GABA- and Glycine-Activated Ionic Currents with Semax in Isolated Cerebral Neurons. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  31. Eremin KO et al. (2004). Effects of Semax on dopaminergic and serotoninergic systems of the brain [PMID: 15088389]

    Laboratory literature summary: Effects of Semax on dopaminergic and serotoninergic systems of the brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  32. Agapova TY et al. (2007). Neurotrophin gene expression in rat brain under the action of Semax, an analogue of… [PMID: 17353092]

    Laboratory literature summary: Neurotrophin gene expression in rat brain under the action of Semax, an analogue of ACTH 4-10. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  33. Shadrina M et al. (2010). Comparison of the temporary dynamics of NGF and BDNF gene expression in rat… [PMID: 19662538]

    Laboratory literature summary: Comparison of the temporary dynamics of NGF and BDNF gene expression in rat hippocampus, frontal cortex, and retina under Semax action. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  34. Levitskaia NG et al. (2010). [Influence of Semax on the emotional state of white rats in the norm and against the… [PMID: 20387390]

    Laboratory literature summary: [Influence of Semax on the emotional state of white rats in the norm and against the background of cholecystokinin-tetrapeptide action]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  35. Shevchenko KV et al. (2013). Stability of Semax acetyl to proteolysis in various biological media [PMID: 23652441]

    Laboratory literature summary: Stability of Semax acetyl to proteolysis in various biological media. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  36. Levitskaya NG et al. (2004). The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the… [PMID: 15341218]

    Laboratory literature summary: The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  37. Yatsenko KA et al. (2013). Heptapeptide semax attenuates the effects of chronic unpredictable stress in rats [PMID: 24385169]

    Laboratory literature summary: Heptapeptide semax attenuates the effects of chronic unpredictable stress in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  38. V'yunova TV et al. (2006). Specific binding of semax in different regions of the rat brain [PMID: 17278839]

    Laboratory literature summary: Specific binding of semax in different regions of the rat brain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  39. Kost NV et al. (2001). [Semax and selank inhibit the enkephalin-degrading enzymes from research subjects serum]] [PMID: 11443939]

    Laboratory literature summary: [Semax and selank inhibit the enkephalin-degrading enzymes from research subjects serum]]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  40. Romanova GA et al. (2006). Neuroprotective and antiamnesic effects of Semax during experimental ischemic… [PMID: 17603664]

    Laboratory literature summary: Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  41. Samotrueva MA et al. (2019). Experimental Substantiation of Application of Semax as a Modulator of Immune Reaction… [PMID: 31028579]

    Laboratory literature summary: Experimental Substantiation of Application of Semax as a Modulator of Immune Reaction on the Model of "Social" Stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  42. Ivanikov IO et al. (2002). Research protocol of peptic ulcer with semax peptide [PMID: 12459874]

    Laboratory literature summary: research protocol of peptic ulcer with semax peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  43. Kolbaev SN et al. (2025). The Effect of Peptide Semax, an ACTH(4-10) Analogue, on Intracellular Calcium Dynamics… [PMID: 41171324]

    Laboratory literature summary: The Effect of Peptide Semax, an ACTH(4-10) Analogue, on Intracellular Calcium Dynamics in Rat Brain Neurons. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  44. Dolotov OV et al. (2003). The heptapeptide SEMAX stimulates BDNF expression in different areas of the rat brain… [PMID: 14556513]

    Laboratory literature summary: The heptapeptide SEMAX stimulates BDNF expression in different areas of the rat brain in vivo. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  45. Sheremet NL et al. (2004). [An experimental substantiation for using the "Semax" neuroprotector in the… [PMID: 15678666]

    Laboratory literature summary: [An experimental substantiation for using the "Semax" neuroprotector in the investigation of optic-nerve diseases]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  46. Stavchansky VV et al. (2011). The effect of Semax and its C-end peptide PGP on the morphology and proliferative… [PMID: 20617398]

    Laboratory literature summary: The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  47. Stavchanskiĭ VV et al. (2013). [The effect of semax and its C-end peptide PGP on Vegfa gene expression in the rat… [PMID: 23888777]

    Laboratory literature summary: [The effect of semax and its C-end peptide PGP on Vegfa gene expression in the rat brain during incomplete global ischemia]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  48. Inozemtseva LS et al. (2024). Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax… [PMID: 39442746]

    Laboratory literature summary: Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on research models rats in a model…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  49. Storozhevykh TP et al. (2007). Effects of semax and its Pro-Gly-Pro fragment on calcium homeostasis of neurons and… [PMID: 18239779]

    Laboratory literature summary: Effects of semax and its Pro-Gly-Pro fragment on calcium homeostasis of neurons and their survival under conditions of glutamate toxicity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  50. Iasnetsov VV et al. (2010). [Antihypoxic and antiamnesic effects of mexidol and semax] [PMID: 20486550]

    Laboratory literature summary: [Antihypoxic and antiamnesic effects of mexidol and semax]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  51. Inozemtsev AN et al. (2013). Semax prevents functional impairments of avoidance response in rats [PMID: 23479006]

    Laboratory literature summary: Semax prevents functional impairments of avoidance response in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  52. Koroleva MV et al. (1996). [Study of the analgesic effect of the semax preparation] [PMID: 8998343]

    Laboratory literature summary: [Study of the analgesic effect of the semax preparation]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  53. Sebentsova EA et al. (2006). Effects of semax against the background of dopaminergic receptor blockade with haloperidol [PMID: 16984088]

    Laboratory literature summary: Effects of semax against the background of dopaminergic receptor blockade with haloperidol. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  54. Inozemtsev AN et al. (2013). [Opposite Semax influence on conditioning and functional disturbances of avoidance… [PMID: 25464761]

    Laboratory literature summary: [Opposite Semax influence on conditioning and functional disturbances of avoidance responses in rats]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  55. Grigorjeva ME et al. (2010). Anticoagulation and antiplatelet effects of semax under conditions of acute and… [PMID: 21113455]

    Laboratory literature summary: Anticoagulation and antiplatelet effects of semax under conditions of acute and chronic immobilization stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  56. Dolotov OV et al. (2004). [The binding of Semax, ACTH 4-10 heptapeptide, to plasma membranes of the rat… [PMID: 15344653]

    Laboratory literature summary: [The binding of Semax, ACTH 4-10 heptapeptide, to plasma membranes of the rat forebrain basal nuclei and its biodegradation]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  57. Agapova TY et al. (2007). Expression changes caused by the peptide semax in the intracellular signal pathway… [PMID: 18274453]

    Laboratory literature summary: Expression changes caused by the peptide semax in the intracellular signal pathway genes in rat hippocamp. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  58. Svishcheva MV et al. (2021). Morphofunctional State of the Large Intestine in Rats under Conditions of Restraint… [PMID: 33459919]

    Laboratory literature summary: Morphofunctional State of the Large Intestine in Rats under Conditions of Restraint Stress and Administration of Peptide ACTH((4-7))-PGP…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  59. Zhuikova SE et al. (2000). Effect of Semax on homeostasis of gastric mucosa in albino rats [PMID: 11177268]

    Laboratory literature summary: Effect of Semax on homeostasis of gastric mucosa in albino rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  60. Dmitrieva VG et al. (2008). The effect of semax and the C-terminal peptide PGP on expression of growth factor… [PMID: 19024553]

    Laboratory literature summary: The effect of semax and the C-terminal peptide PGP on expression of growth factor genes and receptors in rats under conditions of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  61. Gavrilova SA et al. (2017). Changes in Sympathetic Innervation of the Heart in Rats with Experimental Myocardial… [PMID: 28948544]

    Laboratory literature summary: Changes in Sympathetic Innervation of the Heart in Rats with Experimental Myocardial Infarction. Effect of Semax. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  62. Medvedeva EV et al. (2013). Effect of semax and its C-terminal fragment Pro-Gly-Pro on the expression of VEGF… [PMID: 22772900]

    Laboratory literature summary: Effect of semax and its C-terminal fragment Pro-Gly-Pro on the expression of VEGF family genes and their receptors in experimental focal…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  63. Ivanov AV et al. (2017). Influence of ACTG(4-7)-PGP (Semax) on Morphofunctional State of Hepatocytes in Chronic… [PMID: 28577097]

    Laboratory literature summary: Influence of ACTG(4-7)-PGP (Semax) on Morphofunctional State of Hepatocytes in Chronic Emotional and Painful Stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  64. Arushanian EB et al. (2008). [Chronotropic activity of semax] [PMID: 18488900]

    Laboratory literature summary: [Chronotropic activity of semax]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  65. Ivanova DM et al. (2003). The effect of semax on animal pain sensitivity in various experimental models [PMID: 12712960]

    Laboratory literature summary: The effect of semax on animal pain sensitivity in various experimental models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  66. Zolotarev YA et al. (2006). Degradation of the ACTH(4-10) analog Semax in the presence of rat basal forebrain cell… [PMID: 16773243]

    Laboratory literature summary: Degradation of the ACTH(4-10) analog Semax in the presence of rat basal forebrain cell cultures and plasma membranes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  67. Bashkatova VG et al. (2001). Novel synthetic analogue of ACTH 4-10 (Semax) but not glycine prevents the enhanced… [PMID: 11245825]

    Laboratory literature summary: Novel synthetic analogue of ACTH 4-10 (Semax) but not glycine prevents the enhanced nitric oxide generation in cerebral cortex of rats…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  68. Safarova ER et al. (2002). Trophic effects of nootropic peptide preparations cerebrolysin and semax on cultured… [PMID: 12124658]

    Laboratory literature summary: Trophic effects of nootropic peptide preparations cerebrolysin and semax on cultured rat pheochromocytoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  69. Zhuikova SE et al. (2002). Possible mechanism underlying the effect of Semax on the formation of… [PMID: 12447470]

    Laboratory literature summary: Possible mechanism underlying the effect of Semax on the formation of indomethacin-induced ulcers in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  70. Grigoriev VV et al. (2015). The action of the peptide drug Semax on the currents of AMPA receptors of rat… [PMID: 25772990]

    Laboratory literature summary: The action of the peptide drug Semax on the currents of AMPA receptors of rat cerebellar Purkinje cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  71. Volodina MA et al. (2012). Correction of long-lasting negative effects of neonatal isolation in white rats using… [PMID: 22708068]

    Laboratory literature summary: Correction of long-lasting negative effects of neonatal isolation in white rats using semax. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  72. Potaman VN et al. (1991). N-terminal degradation of ACTH(4-10) and its synthetic analog semax by the rat blood… [PMID: 1851003]

    Laboratory literature summary: N-terminal degradation of ACTH(4-10) and its synthetic analog semax by the rat blood enzymes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  73. Gusev EI et al. (1997). Laboratory research record on Semax [PMID: 11517472]

    PubMed laboratory record discussing Semax in a research context. Review the full methods and limitations on PubMed; research use only.

  74. Shevchenko KV et al. (2013). Study of proteolysis of Semax analogues with different N-terminal amino acids by… [PMID: 23821053]

    Laboratory literature summary: Study of proteolysis of Semax analogues with different N-terminal amino acids by carboxypeptidases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  75. Agapova TIu et al. (2008). [Effect of semax on the temporary dynamics of brain-derived neurotrophic factor and… [PMID: 18756821]

    Laboratory literature summary: [Effect of semax on the temporary dynamics of brain-derived neurotrophic factor and nerve growth factor gene expression in the rat…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  76. Shevchenko KV et al. (2006). [Kinetics of Semax penetration into the brain and blood of rats after its intranasal… [PMID: 16523722]

    Laboratory literature summary: [Kinetics of Semax penetration into the brain and blood of rats after its intranasal administration]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  77. Zhuĭkova SE et al. (2003). Laboratory research record on Semax [PMID: 14653248]

    PubMed laboratory record discussing Semax in a research context. Review the full methods and limitations on PubMed; research use only.

  78. Levitskaya NG et al. (2000). Study on the neurotropic activity of the products of Semax enzymatic degradation [PMID: 10944712]

    Laboratory literature summary: Study on the neurotropic activity of the products of Semax enzymatic degradation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  79. Safarova ER et al. (2003). Effect of Semax peptide on survival of cultured rat pheochromocytoma cells during… [PMID: 12802399]

    Laboratory literature summary: Effect of Semax peptide on survival of cultured rat pheochromocytoma cells during oxidative stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  80. Shevchenko KV et al. (2009). The use of phospholipid nanoparticles for increasing Semax resistance in various… [PMID: 20170058]

    Laboratory literature summary: The use of phospholipid nanoparticles for increasing Semax resistance in various proteolytic biological media. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  81. Kopylova GN et al. (2003). Glyprolines and semax prevent stress-induced microcirculatory disturbances in the… [PMID: 14968154]

    Laboratory literature summary: Glyprolines and semax prevent stress-induced microcirculatory disturbances in the mesentery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  82. Ivanova DM et al. (2007). Comparative study of analgesic potency of ACTH4-10 fragment and its analog semax [PMID: 18018999]

    Laboratory literature summary: Comparative study of analgesic potency of ACTH4-10 fragment and its analog semax. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  83. Stavchanskiĭ VV et al. (2011). [The effect of semax and its C-end peptide PGP on expression of the neurotrophins and… [PMID: 22295573]

    Laboratory literature summary: [The effect of semax and its C-end peptide PGP on expression of the neurotrophins and their receptors in the rat brain during incomplete…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  84. Kurysheva NI et al. (2001). [Semax in the investigation of glaucomatous optic neuropathy in research subjects with… [PMID: 11569188]

    Laboratory literature summary: [Semax in the investigation of glaucomatous optic neuropathy in research subjects with normalized ophthalmic tone]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  85. Gusev EI et al. (2005). [Semax in prevention of disease progress and development of exacerbations in research… [PMID: 15792140]

    Laboratory literature summary: [Semax in prevention of disease progress and development of exacerbations in research subjects with cerebrovascular insufficiency]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  86. Koroleva MV et al. (1996). [Effect of the heptapeptide Semax on the research subjects electroencephalogram] [PMID: 8679991]

    Laboratory literature summary: [Effect of the heptapeptide Semax on the research subjects electroencephalogram]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  87. Gorbacheva AM et al. (2016). Changes in Sympathetic Innervation of Rat Caudal Artery in Experimental Myocardial… [PMID: 27591879]

    Laboratory literature summary: Changes in Sympathetic Innervation of Rat Caudal Artery in Experimental Myocardial Infarction. Effect of Semax Peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  88. Fadyukova OE et al. (2011). Semax increases erythrocyte deformability in the shearing blood stream in intact rats… [PMID: 21953224]

    Laboratory literature summary: Semax increases erythrocyte deformability in the shearing blood stream in intact rats and rats with cerebral ischemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  89. Bezuglov VV et al. (2014). [Antiaggregation activity of arachidonic acid conjugates with neurotropic peptides… [PMID: 25102733]

    Laboratory literature summary: [Antiaggregation activity of arachidonic acid conjugates with neurotropic peptides proglyprol and semax]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  90. Astashkin EI et al. (2000). Effects of Semax on Ca2+ responses of research subjects neutrophils [PMID: 11103338]

    Laboratory literature summary: Effects of Semax on Ca2+ responses of research subjects neutrophils. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  91. Astashkin EI et al. (2001). Effects of Semax, a peptide ACTH4-10 analogue, on the respiratory burst in research… [PMID: 12918351]

    Laboratory literature summary: Effects of Semax, a peptide ACTH4-10 analogue, on the respiratory burst in research subjects neutrophils. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  92. Shadrina MI et al. (2001). Rapid induction of neurotrophin mRNAs in rat glial cell cultures by Semax, an… [PMID: 11457573]

    Laboratory literature summary: Rapid induction of neurotrophin mRNAs in rat glial cell cultures by Semax, an adrenocorticotropic hormone analog. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  93. Shypshyna MS et al. (2015). [EFFECT OF PEPTIDE SEMAX ON SYNAPTIC ACTIVITY AND SHORT-TERM PLASTICITY OF… [PMID: 26552305]

    Laboratory literature summary: [EFFECT OF PEPTIDE SEMAX ON SYNAPTIC ACTIVITY AND SHORT-TERM PLASTICITY OF GLUTAMATERGIC SYNAPSES OF CO-CULTURED DORSAL ROOT GANGLION…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  94. Alekseeva GV et al. (1999). [Use of semax at a follow-up of research subjects with posthypoxic encephalopathy] [PMID: 10199046]

    Laboratory literature summary: [Use of semax at a follow-up of research subjects with posthypoxic encephalopathy]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  95. Levitskaia NG et al. (2002). [Neuroprotective effects of semax in MPTP-induced disturbances of brain dopamine system] [PMID: 12587264]

    Laboratory literature summary: [Neuroprotective effects of semax in MPTP-induced disturbances of brain dopamine system]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  96. Shilova OB et al. (2004). [Neonatal Semax and saline parenteral-route administration induce open-field behavior… [PMID: 15658043]

    Laboratory literature summary: [Neonatal Semax and saline parenteral-route administration induce open-field behavior changes in mice of different genotypes]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  97. Arushanian EB et al. (2009). [Effect of semax on heart rate variability in various daytime periods] [PMID: 19441725]

    Laboratory literature summary: [Effect of semax on heart rate variability in various daytime periods]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  98. Cherkasova KA et al. (2001). Comparative study of modulatory effects of Semax and primary proline-containing… [PMID: 11687836]

    Laboratory literature summary: Comparative study of modulatory effects of Semax and primary proline-containing peptides on hemostatic reactions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  99. Timoshenko TV et al. (2009). Effect of neonatal parenteral-route administration of the neuropeptide Semax on cell… [PMID: 19341092]

    Laboratory literature summary: Effect of neonatal parenteral-route administration of the neuropeptide Semax on cell proliferation in hippocampal dentate area in rats…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  100. Asmarin IP et al. (1997). [A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design… [PMID: 9173745]

    Laboratory literature summary: [A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  101. Eremin KO et al. (2004). [Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in… [PMID: 15188751]

    Laboratory literature summary: [Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in the Sprague-Dawley rat striatum and on the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  102. Boyarshinova OS et al. (2004). Neonatal administration of ACTH4-10 and its analog Semax to young laboratory mice… [PMID: 15354819]

    Laboratory literature summary: Neonatal administration of ACTH4-10 and its analog Semax to young laboratory mice modulates the number of catecholaminergic neurons in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  103. Iakovleva EV et al. (1999). [Study of the observed endpoints of semax in global cerebral ischemia in vivo] [PMID: 11188738]

    Laboratory literature summary: [Study of the observed endpoints of semax in global cerebral ischemia in vivo]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  104. Maev IV et al. (2003). [New regulatory peptides in rat stomach secretion (amylin, PGP, semax)] [PMID: 12875006]

    Laboratory literature summary: [New regulatory peptides in rat stomach secretion (amylin, PGP, semax)]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  105. Bakhmet AA et al. (2012). Antistress effect of Semax in the course of recovery of spleen lymphoid structures… [PMID: 23113251]

    Laboratory literature summary: Antistress effect of Semax in the course of recovery of spleen lymphoid structures after the stress in rats with different behavioral…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  106. Vilenskiĭ DA et al. (2007). [Effects of chronic Semax administration on exploratory activity and emotional… [PMID: 17850024]

    Laboratory literature summary: [Effects of chronic Semax administration on exploratory activity and emotional reaction in white rats]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  107. Polunin GS et al. (2000). [Evaluation of investigational effect of new Russian drug semax in optic nerve disease] [PMID: 10741256]

    Laboratory literature summary: [Evaluation of investigational effect of new Russian drug semax in optic nerve disease]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  108. Miasoedova NF et al. (1999). Laboratory research record on Semax [PMID: 10358912]

    PubMed laboratory record discussing Semax in a research context. Review the full methods and limitations on PubMed; research use only.

  109. Ivanova DM et al. (2006). Effect of Semax on changes in pain sensitivity and behavior of animals induced by… [PMID: 16739472]

    Laboratory literature summary: Effect of Semax on changes in pain sensitivity and behavior of animals induced by forced swimming. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  110. Serdiuk AV et al. (2007). [The study of chronic partial denervation and quality of life in research subjects… [PMID: 18379501]

    Laboratory literature summary: [The study of chronic partial denervation and quality of life in research subjects with motor neuron disease studied with semax]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  111. Boyarshinova OS et al. (2008). Audiogenic epilepsy in young mice of different strains after neonatal semax investigation [PMID: 19145359]

    Laboratory literature summary: Audiogenic epilepsy in young mice of different strains after neonatal semax investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  112. Shevchenko KV et al. (2011). [Proteolysis of semax analogues with different N-terminal amino acids by aminopeptidases] [PMID: 22096989]

    Laboratory literature summary: [Proteolysis of semax analogues with different N-terminal amino acids by aminopeptidases]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  113. Maslova MV et al. (1999). [Effect of heptapeptide semax on the cardiac activity in acute hypobaric hypoxia… [PMID: 11188735]

    Laboratory literature summary: [Effect of heptapeptide semax on the cardiac activity in acute hypobaric hypoxia during the early postnatal period]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  114. Ivanov IuV et al. (2000). [The effect of semax and mexidol on the course of acute pancreatitis in rats] [PMID: 10763109]

    Laboratory literature summary: [The effect of semax and mexidol on the course of acute pancreatitis in rats]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  115. Volodina MA et al. (2014). [Effects of neonatal fluvoxamine administration to white rats and their correction by… [PMID: 25735182]

    Laboratory literature summary: [Effects of neonatal fluvoxamine administration to white rats and their correction by semax investigation]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  116. Khugaeva VK et al. (1997). [Relationship between the investigational effect of the peptide preparation semax and… [PMID: 9303728]

    Laboratory literature summary: [Relationship between the investigational effect of the peptide preparation semax and the severity of brain ischemia]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  117. Gavrilova SA et al. (2006). [Protective effect of peptide semax (ACTH(4-7)Pro-Gly-Pro) on the rat heart rate after… [PMID: 17385423]

    Laboratory literature summary: [Protective effect of peptide semax (ACTH(4-7)Pro-Gly-Pro) on the rat heart rate after myocardial infarction]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  118. Iasnetsov VV et al. (2009). [Effect of semax and mexidol on brain ischemia models in rats] [PMID: 19334516]

    Laboratory literature summary: [Effect of semax and mexidol on brain ischemia models in rats]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  119. Fadiukova OE et al. (2001). [Semax prevents elevation of nitric oxide generation caused by incomplete global… [PMID: 11548444]

    Laboratory literature summary: [Semax prevents elevation of nitric oxide generation caused by incomplete global ischemia in the rat brain]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  120. Umriukhin PE et al. (2001). [Gene c-Fos expression in brain of rats resistant and predisposed to emotional stress… [PMID: 11548604]

    Laboratory literature summary: [Gene c-Fos expression in brain of rats resistant and predisposed to emotional stress after intraperitoneal parenteral-route…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  121. Golubeva AV et al. (2006). [Protective effect of peptide semax the rat heart in acute myocardial infarction] [PMID: 16967870]

    Laboratory literature summary: [Protective effect of peptide semax the rat heart in acute myocardial infarction]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  122. Iasnetsov VV et al. (1998). [Effects of semax and ACTH(5-10) on the impulse activity of central neurons] [PMID: 9606550]

    Laboratory literature summary: [Effects of semax and ACTH(5-10) on the impulse activity of central neurons]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  123. Sebentsova EA et al. (2005). [Dependence of long-lasting effects of the ACTH(4-10) analogue semax on the time of… [PMID: 15835535]

    Laboratory literature summary: [Dependence of long-lasting effects of the ACTH(4-10) analogue semax on the time of its neonatal administration]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  124. Potaman VN et al. (1993). Degradation of ACTH/MSH(4-10) and its synthetic analog semax by rat serum enzymes: an… [PMID: 8392718]

    Laboratory literature summary: Degradation of ACTH/MSH(4-10) and its synthetic analog semax by rat serum enzymes: an inhibitor study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  125. Umarova BA et al. (2003). Secretory activity of mast cell during stress: effect of prolyl-glycyl-proline and Semax [PMID: 14714073]

    Laboratory literature summary: Secretory activity of mast cell during stress: effect of prolyl-glycyl-proline and Semax. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  126. Kaplan AIa et al. (1992). [Increased resistance to hypoxia effected by the neuropeptide preparation SEMAX] [PMID: 1335426]

    Laboratory literature summary: [Increased resistance to hypoxia effected by the neuropeptide preparation SEMAX]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  127. Orlov AV et al. (1999). [Effect of semax and its mixture with heparin on the activity of isolated heart after… [PMID: 10640229]

    Laboratory literature summary: [Effect of semax and its mixture with heparin on the activity of isolated heart after total ischemia]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  128. Ivanov IuV (2000). [Ultrastructural changes in the pancreas of rats with acute pancreatitis after semax… [PMID: 11202510]

    Laboratory literature summary: [Ultrastructural changes in the pancreas of rats with acute pancreatitis after semax administration]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  129. Fadyukova OE et al. (2005). C-terminal Pro-Gly-Pro tripeptide in contrast to full-length neuropeptide semax… [PMID: 16027870]

    Laboratory literature summary: C-terminal Pro-Gly-Pro tripeptide in contrast to full-length neuropeptide semax exhibits no neuroprotective effect in experimental…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  130. Glazova NIu et al. (2005). [Effect of modification of the N-terminal region of molecule on the expression of… [PMID: 16212268]

    Laboratory literature summary: [Effect of modification of the N-terminal region of molecule on the expression of neotropic effect of semax analogues]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  131. Sebentsova EA et al. (2005). [Long-lasting behavioral effects of chronic neonatal investigation with ACTH (4-10)… [PMID: 15895862]

    Laboratory literature summary: [Long-lasting behavioral effects of chronic neonatal investigation with ACTH (4-10) analogue semax in white rat pups]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  132. Romanova GA et al. (2012). [The comparison of neuroprotective action of antibodies to glutamate and drug… [PMID: 23072114]

    Laboratory literature summary: [The comparison of neuroprotective action of antibodies to glutamate and drug preparation semax in the focal ischemic damage of the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  133. Bastrikova NA et al. (1999). [The biogenic amine content of rat tissues in the postresuscitation period following… [PMID: 10498989]

    Laboratory literature summary: [The biogenic amine content of rat tissues in the postresuscitation period following hemorrhagic shock and the effect of the preparation…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight .125 lbs
Dimensions 8 × 7 × .5 in
Size: No selection

5 mg, 10 mg, 30 mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is Semax peptide?

Semax is a synthetic peptide derived from adrenocorticotropic hormone (ACTH) fragments. It is studied in research laboratories for its role in neuropeptide signaling and central nervous system-related pathways.

What is Semax used for in research?

Semax is used in research laboratories to investigate neuropeptide activity, receptor interactions, and cognitive-related signaling pathways. It is not approved for human use.

Is Semax Peptide approved or intended for human use?

No. Semax is strictly intended for research purposes only and is not approved by the FDA for human use.

Is Semax Peptide FDA-approved for medical or clinical use?

No. Semax is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is Semax supplied?

Semax is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should Semax be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for Semax?

Semax is available in multiple vial sizes.

Is Semax Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is Semax shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments

How can I verify Semax purity and quality?

Product quality is supported through third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency. For more info, visit: https://www.nationwidepeptides.com/coa/